About

Established in 1991, JJET is located in the Wuhou National Science Park within Chengdu’s High-Tech Industry Development Zone. The company occupies an area of 22,805 sq. meters for office, R&D, and production facilities. For decades, JJET has been focused on the R&D, production, and marketing of cardiac electrophysiology devices, including the 3Ding Cardiac Mapping System, Electrophysiology Recording System, Cardiac RF Ablation Generator, Irrigation Pump, Electrophysiology Catheters, Ablation Catheters, Neural RF Generator etc. With sales networks across China, JJET has over 1,000 institutional users. It constantly strives to pursue scientific and technological innovations. At present, the proportion of R&D personnel is more than 23% of total staff, having obtained 71 authorized patents and 73 patents in application process. As a pioneer in Chinese electrophysiology industry, we are committed to providing comprehensive solutions to cure arrhythmia.

Our Mission

Leading the field of cardiac electrophysiology interventional therapy in China, JJET is dedicated to providing high-quality products for patients to improve the quality of life. We take pride in creating innovative solutions that contribute to human health.

Milestones

In 1991, JJET was established and developed the Cardiac RF Ablation Generator;
In 1993, the Cardiac RF Ablation Generator won the second prize of PLA Scientific and Technological Progress Award;
In 1995, the Cardiac RF Ablation Generator won the second prize of National Scientific and Technological Progress Award;
In 1996, JJET developed the Full-digital Multichannel EP Management System;
In 2003, JJET Obtained the National High-tech Enterprise Certificate;
In 2003,JJET obtained the “ISO9001+YY/T 0287 idt ISO 13485” certificate of quality system;
In 2003, JJET developed the Multichannel Blood Pressure Monitoring System with pressure wire measuring and analyzing functions;
In 2004, JJET signed a collaboration agreement with C.R. BARD, INC. an internationally renowned company in the field of cardiac electrophysiology;

In 2004, JJET relocated to the Wuhou National Science Park in the High-Tech Industry Development Zone of Chengdu;

In 2005, Cardiac RF Ablation Generator obtained the patient support Of Innovation Fund for Technology Based Firms and passed the acceptable;
In 2007, JJET obtained the Certificate of Growth Enterprise of Sichuan Province;
In 2007, H-100G Cardiac RF Ablation Generator entered international markets (the first of its kind among Chinese producers to enter U.S and E.U EP-labs);
In 2008, JJET passed the new version of the National High-Tech Enterprise Re-identification;
In 2008,JJET was awarded the title of Innovation Cultivation Enterprise of Sichuan Province;
In 2009, JJET developed the 3Ding Cardiac Mapping System;
In 2009, the Electrophysiology Recording System received the Technology R&D Program special support of Sichuan Province;
In 2009, the Electrophysiology Recording System received the Technical Innovation Project Plan special support of Sichuan Province;
In 2011, JJET successfully acquired American catheter producer, CARDIMA INC;
In 2013, 3DING Cardiac Mapping System was approved by China Food and Drug Administation(CFDA);
In 2014, established a joint-venture company- Suzhou Xinmai Medical Equipment Co.,Ltd in Suzhou Industrial Park;
In 2015, LEAD-EP Recording System and Cardiac RF Ablation Generator obtained CE certification;
In 2018,  JJET officially set up partnership with Shenzhen Salubris Pharmaceuticals Co., Ltd. with an investment and financial cooperation agreement;
In 2020 , Electrophysiology Catheters and Ablation Catheters was approval by National Medical Products Administration(NMPA).